Difference of IFI44L methylation and serum IFN-a1 level among patients with discoid and systemic lupus erythematosus and healthy individuals

Jin, 2016, Old lines tell new tales: blaschko linear lupus erythematosis, Autoimmun. Rev., 15, 291, 10.1016/j.autrev.2015.11.014 Jin, 2020, A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum, Lupus, 29, 1854, 10.1177/0961203320959716 Wieczorek, 2014, Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus, JAMA dermatology, 150, 291, 10.1001/jamadermatol.2013.9026 Stec-Polak, 2019, Higher specificity of the new EULAR/ACR 2019 criteria for diagnosing systemic lupus erythematosus in patients with biopsy-proven cutaneous lupus, Clin. Exp. Rheumatol. Zhou, 2020, New insights into the progression from cutaneous lupus to systemic lupus erythematosus, Expet Rev. Clin. Immunol., 16, 829, 10.1080/1744666X.2020.1805316 Hersh, 2016, Immunogenetics of cutaneous lupus erythematosus, Curr. Opin. Pediatr., 28, 470, 10.1097/MOP.0000000000000383 Berthier, 2019, Molecular profiling of cutaneous lupus lesions identifies subgroups distinct from clinical phenotypes, J. Clin. Med., 8 Méndez-Flores, 2019, MicroRNA expression in cutaneous lupus: a new window to understand its pathogenesis, Mediat. Inflamm., 2019, 5049245, 10.1155/2019/5049245 Hile, 2020, Immunopathogenesis of skin injury in systemic lupus erythematosus, Curr. Opin. Rheumatol., 332, 10.1097/BOR.0000000000000770 Maz, 2020, Cutaneous and systemic connections in lupus, Curr. Opin. Rheumatol., 32, 583, 10.1097/BOR.0000000000000739 Lambers, 2019, Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin, Arthritis Res. Ther., 21, 260, 10.1186/s13075-019-2034-4 Zhao, 2016, IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus, Ann. Rheum. Dis., 75, 1998, 10.1136/annrheumdis-2015-208410 Zhang, 2020, A simple and highly efficient method of IFI44L methylation detection for the diagnosis of systemic lupus erythematosus, Clinical immunology (Orlando, Fla, 221, 108612, 10.1016/j.clim.2020.108612 Huang, 2018, IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway, BMC Canc., 18, 609, 10.1186/s12885-018-4529-9 Niewold, 2011, Interferon alpha as a primary pathogenic factor in human lupus, J. Interferon Cytokine Res. : the official journal of the International Society for Interferon and Cytokine Research, 31, 887, 10.1089/jir.2011.0071 Zhao, 2016, IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus, Ann. Rheum. Dis., 75, 1998, 10.1136/annrheumdis-2015-208410 Luo, 2020, Recent advances in understanding pathogenesis and therapeutic strategies of Systemic Lupus Erythematosus, Int. Immunopharm., 89, 107028, 10.1016/j.intimp.2020.107028 Li, 2018, A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus, J. Autoimmun., 93, 1, 10.1016/j.jaut.2018.07.007 Braunstein, 2012, The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score, Br. J. Dermatol., 166, 971, 10.1111/j.1365-2133.2012.10825.x Mathian, 2019, Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse, Ann. Rheum. Dis., 78, 1669, 10.1136/annrheumdis-2019-215571 Patsinakidis, 2016, Cutaneous characteristics and association with antinuclear antibodies in 402 patients with different subtypes of lupus erythematosus, J. Eur. Acad. Dermatol. Venereol. : JEADV, 30, 2097, 10.1111/jdv.13769 Vrba, 2019, DNA methylation changes in biomarker loci occur early in cancer progression, F1000Research, 8, 2106, 10.12688/f1000research.21584.1